These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2552077)

  • 1. Spinal analgesic actions of kappa receptor agonists, U-50488H and spiradoline (U-62066).
    Piercey MF; Einspahr FJ
    J Pharmacol Exp Ther; 1989 Oct; 251(1):267-71. PubMed ID: 2552077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analgesic and mechanistic evaluation of spiradoline, a potent kappa opioid.
    Vonvoigtlander PF; Lewis RA
    J Pharmacol Exp Ther; 1988 Jul; 246(1):259-62. PubMed ID: 2839665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of chronic administration of U-50,488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord.
    Bhargava HN; Gulati A; Ramarao P
    J Pharmacol Exp Ther; 1989 Oct; 251(1):21-6. PubMed ID: 2552075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
    Millan MJ; Członkowski A; Lipkowski A; Herz A
    J Pharmacol Exp Ther; 1989 Oct; 251(1):342-50. PubMed ID: 2571723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similar actions of kappa and mu agonists on spinal nociceptive reflexes in rats and their reversibility by naloxone.
    Parsons CG; West DC; Headley PM
    NIDA Res Monogr; 1986; 75():461-4. PubMed ID: 2828992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
    Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinociceptive actions of dexmedetomidine and the kappa-opioid agonist U-50,488H against noxious thermal, mechanical and inflammatory stimuli.
    Idänpään-Heikkilä JJ; Kalso EA; Seppälä T
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1306-13. PubMed ID: 7996439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord.
    Tseng LF; Narita M; Mizoguchi H; Kawai K; Mizusuna A; Kamei J; Suzuki T; Nagase H
    J Pharmacol Exp Ther; 1997 Feb; 280(2):600-5. PubMed ID: 9023269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.
    Vonvoigtlander PF; Lahti RA; Ludens JH
    J Pharmacol Exp Ther; 1983 Jan; 224(1):7-12. PubMed ID: 6129321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antinociceptive action of intracerebroventricularly administered dynorphin and other opioid peptides in the rat.
    Tiseo PJ; Geller EB; Adler MW
    J Pharmacol Exp Ther; 1988 Aug; 246(2):449-53. PubMed ID: 2900324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective kappa opioid agonist for spinal analgesia without the risk of respiratory depression.
    Castillo R; Kissin I; Bradley EL
    Anesth Analg; 1986 Apr; 65(4):350-4. PubMed ID: 3006552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse.
    Tseng LF; Collins KA
    J Pharmacol Exp Ther; 1996 Oct; 279(1):39-46. PubMed ID: 8858973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative studies on the affinities of K-II and U-50488H for kappa opiate receptor].
    Li JG; Ma SC; Lu SN; Wang CQ
    Yao Xue Xue Bao; 1991; 26(1):10-4. PubMed ID: 1653514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release by U-50,488H of [3H]serotonin from brain slices and spinal cord synaptosomes of U-50,488H-tolerant and nontolerant mice.
    Ho BY; Takemori AE
    J Pharmacol Exp Ther; 1990 Jul; 254(1):8-12. PubMed ID: 2164102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kappa opioid analgesia is dependent on serotonergic mechanisms.
    Vonvoigtlander PF; Lewis RA; Neff GL
    J Pharmacol Exp Ther; 1984 Nov; 231(2):270-4. PubMed ID: 6092612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. U-50488H, a pure kappa receptor agonist with spinal analgesic loci in the mouse.
    Piercey MF; Lahti RA; Schroeder LA; Einspahr FJ; Barsuhn C
    Life Sci; 1982 Sep 20-27; 31(12-13):1197-200. PubMed ID: 6292608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex and rat strain determine sensitivity to kappa opioid-induced antinociception.
    Barrett AC; Cook CD; Terner JM; Roach EL; Syvanthong C; Picker MJ
    Psychopharmacology (Berl); 2002 Mar; 160(2):170-81. PubMed ID: 11875635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of nitric oxide synthase enhances antinociception mediated by mu, delta and kappa opioid receptors in acute and prolonged pain in the rat spinal cord.
    Machelska H; Labuz D; Przewłocki R; Przewłocka B
    J Pharmacol Exp Ther; 1997 Aug; 282(2):977-84. PubMed ID: 9262366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kappa agonist-induced reduction in dopamine release: site of action and tolerance.
    Donzanti BA; Althaus JS; Payson MM; Von Voigtlander PF
    Res Commun Chem Pathol Pharmacol; 1992 Nov; 78(2):193-210. PubMed ID: 1282270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of mu-, delta- and kappa-opiate receptor agonists on the bioelectrical activity of the viscerosomatic convergent neurons in the posterior horn of the spinal cord].
    Kasparov SA
    Eksp Klin Farmakol; 1993; 56(1):13-6. PubMed ID: 8391888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.